PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.\', \'Stanford ChEM-H and Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA.\', \'Department of Structural Biology, Stanford University, Stanford, USA.\', \'ATUM, Newark, CA, USA.\', \'Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University, Stanford, CA, USA.\', \'Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USA.\', \'Stanford Blood Center, Palo Alto, CA, USA.\', \'Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA.\', \'Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California, USA.\', \'Chan Zuckerberg Biohub, San Francisco, CA, USA.\', \'Department of Bioengineering, Stanford University, Stanford, CA, USA.\', \'Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA.\', \'Department of Statistics, Stanford University, Stanford, CA, USA.\', \'Department of Biomedical Data Sciences, Stanford University, Stanford, CA, USA.\', \'Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. sboyd1@stanford.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • eabe024010.1126/sciimmunol.abe0240
?:hasPublicationType
?:journal
  • Science immunology
is ?:pmid of
?:pmid
?:pmid
  • 33288645
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all